Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Img, 2010; 3:691-698, doi:10.1016/j.jcmg.2010.04.011
© 2010 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, K.
Right arrow Articles by Ozaki, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Inoue, K.
Right arrow Articles by Ozaki, Y.

Serial Coronary CT Angiography–Verified Changes in Plaque Characteristics as an End Point

Evaluation of Effect of Statin Intervention

Kaori Inoue, MD*, Sadako Motoyama, MD, PhD*,*, Masayoshi Sarai, MD, PhD*, Takahisa Sato, MD, PhD*, Hiroto Harigaya, MD*, Tomonori Hara, MD*, Yoshihiro Sanda, MD{dagger}, Hirofumi Anno, MD, PhD{dagger}, Takeshi Kondo, MD, PhD{ddagger}, Nathan D. Wong, PhD§, Jagat Narula, MD, PhD§, Yukio Ozaki, MD, PhD*

* Department of Cardiology, Fujita Health University, Toyoake, Japan
{dagger} Department of Radiology, Fujita Health University, Toyoake, Japan
{ddagger} Department of Cardiology, Takase Clinic, Takasaki, Japan
§ Division of Cardiology, University of California Irvine School of Medicine, Irvine, California

* Reprint requests and correspondence: Dr. Sadako Motoyama, Department of Cardiology, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan (Email: sadakom{at}fujita-hu.ac.jp).

Objectives: This study sought to assess, by serial computed tomography angiography (CTA), the effect of statin treatment on coronary plaque morphology.

Background: In addition to the assessment of luminal stenosis, CTA also allows characterization of plaque morphology. Large, positively remodeled plaques with large necrotic cores have been reported as indicators of plaque instability.

Methods: CTA was performed in 32 patients (26 men, ages 64.3 ± 8.5 years). Of these, 24 received fluvastatin after the baseline study; 8 subjects who refused statin treatment were followed as the control subjects. Serial imaging was performed after a median interval of 12 months. All vessels were examined in every subject, and a 10-mm-long segment was identified for comparison before and after intervention. Total plaque volume, low attenuation plaque (LAP) volume, lumen volume, and remodeling index were calculated.

Results: In the statin-treated patients, the total plaque volume (92.3 ± 37.7 vs. 76.4 ± 26.5 mm3, p < 0.01) and LAP volume (4.9 ± 7.8 vs. 1.3 ± 2.3 mm3, p = 0.01) were significantly reduced over time; however, there was no change in the lumen volume (63.9 ± 25.3 vs. 65.2 ± 26.2 mm3, p = 0.59). On the other hand, no change was observed in the CTA characteristics in the control subjects, including total plaque volume (94.4 ± 21.2 vs. 98.4 ± 28.6 mm3, p = 0.48), LAP volume (2.1 ± 3.0 vs. 2.3 ± 3.6 mm3, p = 0.91), and lumen volume (80.5 ± 20.7 vs. 75.0 ± 16.3 mm3, p = 0.26). The plaque volume change (–15.9 ± 22.2 vs. 4.0 ± 14.0 mm3, p = 0.01) and LAP volume change (–3.7 ± 7.0 vs. 0.2 ± 1.5 mm3, p < 0.01) were significantly greater in the statin than the control group. The lumen volume (1.3 ± 15.6 vs. –5.5 ± 13.1 mm3, p = 0.24) and remodeling index (–2.4 ± 6.8% vs. –0.3 ± 6.5%, p = 0.53) did not show the significant differences between the 2 groups. The decrease in the plaque volume was due to reduction in the LAP volume (R = 0.83, p < 0.01), and was not related to any changes in the lumen volume (R = 0.21, p = 0.24).

Conclusions: This preliminary study suggests that serial CTA evaluation of coronary plaques allows for the assessment of interval change in the plaque morphology. Statin treatment results in decreases in the plaque and necrotic core volume. The features known to be associated with plaque instability.

Key Words: statins • atherosclerosis • coronary artery disease • computed tomography • vulnerable plaque

Abbreviations and Acronyms
  CTA = computed tomography angiography
  HDL-C = high-density lipoprotein cholesterol
  IVUS = intravascular ultrasound
  LAP = low attenuation plaque
  RI = remodeling index




This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
S. Voros, S. Rinehart, Z. Qian, P. Joshi, G. Vazquez, C. Fischer, P. Belur, E. Hulten, and T. C. Villines
Coronary Atherosclerosis Imaging by Coronary CT Angiography: Current Status, Correlation With Intravascular Interrogation and Meta-Analysis
J. Am. Coll. Cardiol. Img., May 1, 2011; 4(5): 537 - 548.
[Abstract] [Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link